24/7 suggests eight biotech trading near $5 with big upside potential

• 24/7's Lee Jackson pinpoints eight small-cap biotech ideas, whose stocks all trade near $5 but with big upside potential; each company has promising clinical trials and in some cases FDA-approved products already on the market or soon to arrive.
• Galena Biopharma (GALE) "may be the home run that biotech investors are looking for," and the stock may be an acquisition target; Novavax (NASDAQ:NVAX) has six vaccine candidates undergoing clinical trials and a seventh being readied for a Phase I study later this year.
• Jackson's other favorite biotech opportunities: ARRY, BIOD, PLX, RIGL, SNTA, ZGNX.
• J.P. Morgan has three different ideas for aggressive risk-tolerant investors: ITMN, NPSP and PLX.